Literature DB >> 11023508

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

F F Hsieh1, L A Barnett, W F Green, K Freedman, I Matushansky, A I Skoultchi, L L Kelley.   

Abstract

Progression through the mammalian cell cycle is regulated by cyclins, cyclin- dependent kinases (CDKs), and cyclin-dependent kinase inhibitors (CKIs). The function of these proteins in the irreversible growth arrest associated with terminally differentiated cells is largely unknown. The function of Cip/Kip proteins p21(Cip1) and p27(Kip1) during erythropoietin-induced terminal differentiation of primary erythroblasts isolated from the spleens of mice infected with the anemia-inducing strain of Friend virus was investigated. Both p21(Cip1) and p27(Kip1) proteins were induced during erythroid differentiation, but only p27(Kip1) associated with the principal G(1) CDKs-cdk4, cdk6, and cdk2. The kinetics of binding of p27(Kip1) to CDK complexes was distinct in that p27(Kip1) associated primarily with cdk4 (and, to a lesser extent, cdk6) early in differentiation, followed by subsequent association with cdk2. Binding of p27(Kip1) to cdk4 had no apparent inhibitory effect on cdk4 kinase activity, whereas inhibition of cdk2 kinase activity was associated with p27(Kip1) binding, accumulation of hypo-phosphorylated retinoblastoma protein, and G(1) growth arrest. Inhibition of cdk4 kinase activity late in differentiation resulted from events other than p27(Kip1) binding or loss of cyclin D from the complex. The data demonstrate that p27(Kip1) differentially regulates the activity of cdk4 and cdk2 during terminal erythroid differentiation and suggests a switching mechanism whereby cdk4 functions to sequester p27(Kip1) until a specified time in differentiation when cdk2 kinase activity is targeted by p27(Kip1) to elicit G(1) growth arrest. Further, the data imply that p21(Cip1) may have a function independent of growth arrest during erythroid differentiation. (Blood. 2000;96:2746-2754)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023508

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

Authors:  Karl A Merrick; Sandra Morandell; Chang-Qi Zhu; Ian G Cannell; Christian J Braun; Robert A Grant; Eleanor R Cameron; Ming-Sound Tsao; Michael T Hemann; Michael B Yaffe
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

2.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis.

Authors:  Binghui Li; Nan Jia; Reuben Kapur; Kristin T Chun
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

Review 4.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

Review 5.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

6.  E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts.

Authors:  Kelsey L Swartz; Scott N Wood; Tushar Murthy; Oscar Ramirez; Gangjian Qin; Manoj M Pillai; Sridhar Rao; Alex C Minella
Journal:  Mol Cell Biol       Date:  2016-12-19       Impact factor: 4.272

7.  p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.

Authors:  K P Ng; Q Ebrahem; S Negrotto; R Z Mahfouz; K A Link; Z Hu; X Gu; A Advani; M Kalaycio; R Sobecks; M Sekeres; E Copelan; T Radivoyevitch; J Maciejewski; J C Mulloy; Y Saunthararajah
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

8.  The exosome complex establishes a barricade to erythroid maturation.

Authors:  Skye C McIver; Yoon-A Kang; Andrew W DeVilbiss; Chelsea A O'Driscoll; Jonathan N Ouellette; Nathaniel J Pope; Genis Camprecios; Chan-Jung Chang; David Yang; Eric E Bouhassira; Saghi Ghaffari; Emery H Bresnick
Journal:  Blood       Date:  2014-08-12       Impact factor: 22.113

9.  Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Authors:  Xian Wang; Christopher Sistrunk; Paula L Miliani de Marval; Yongbaek Kim; Marcelo L Rodriguez-Puebla
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  GATA-1-mediated proliferation arrest during erythroid maturation.

Authors:  Marcin Rylski; John J Welch; Ying-Yu Chen; Danielle L Letting; J Alan Diehl; Lewis A Chodosh; Gerd A Blobel; Mitchell J Weiss
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.